{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T02:06:50Z","timestamp":1770948410357,"version":"3.50.1"},"reference-count":166,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1517\/14712598.2010.500283","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T10:25:47Z","timestamp":1276856747000},"page":"1197-1208","source":"Crossref","is-referenced-by-count":15,"title":["The therapeutic potential of TNF-\u03b1 antagonists for skin psoriasis comorbidities"],"prefix":"10.1517","volume":"10","author":[{"given":"G\u00e9rald E","family":"Pi\u00e9rard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Pi\u00e9rard-Franchimont","sequence":"additional","affiliation":[{"name":"University Hospital Sart Tilman, Department of Dermatopathology, B-4000 Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9gory","family":"Szepetiuk","sequence":"additional","affiliation":[{"name":"University Hospital Sart Tilman, Department of Dermatopathology, B-4000 Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Paquet","sequence":"additional","affiliation":[{"name":"University Hospital Sart Tilman, Department of Dermatopathology, B-4000 Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Quatresooz","sequence":"additional","affiliation":[{"name":"University Hospital Sart Tilman, Department of Dermatopathology, B-4000 Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,7,13]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041320"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08135.x"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05663"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61128-3"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000083508"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00629.x"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2010.0816"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.10.6.817"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.5.617"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425677"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2005.10.003"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1496"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.12.7948"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.03.004"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072066"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9233-0"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1155\/MI.2005.273"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.08.011"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400642200"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2005.02143.x"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06440.x"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1586\/17469872.2.1.69"},{"key":"e_1_3_2_25_1","article-title":"Psoriasis comorbidities and anti-TNFalpha therapy using adalimumab (Humira\u00ae)","author":"Pierard-Franchimont C","unstructured":"Pierard-Franchimont C, Henry F, Szepetiuk G, Pierard GE. Psoriasis comorbidities and anti-TNFalpha therapy using adalimumab (Humira\u00ae). Rev Med Liege (In Press)","journal-title":"Rev Med Liege"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.08.006"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.12.1493"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.1.449"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051723"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000211279"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.2003.00198.x"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000076020"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032482"},{"key":"e_1_3_2_35_1","doi-asserted-by":"crossref","unstructured":"Helliwell PS Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005;64:ii3-ii8","DOI":"10.1136\/ard.2004.032318"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630600823369"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/00015550252948130"},{"key":"e_1_3_2_38_1","first-page":"279","article-title":"Prevalence of psoriatic arthritis and joints complaints in a large population of Italian patients hospitalized for psoriasis","volume":"15","author":"Gisondi P","year":"2005","unstructured":"Gisondi P, Girolomoni G, Sampogna F, Prevalence of psoriatic arthritis and joints complaints in a large population of Italian patients hospitalized for psoriasis. Eur J Dermatol 2005;15:279-83","journal-title":"Eur J Dermatol"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03159.x"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg384"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.10.059"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)61511-5"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-008-0050-5"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02235.x"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.075101"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.540"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-006-0707-8"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.03031.x"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.1972"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1135245"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01858.x"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00419.2004"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200422147"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:29:1:81"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.12.1527"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07986.x"},{"key":"e_1_3_2_58_1","first-page":"563","article-title":"Psoriasis and the metabolic syndrome","volume":"7","author":"Gottlieb AB","year":"2008","unstructured":"Gottlieb AB, Dann F, Menter A. Psoriasis and the metabolic syndrome. J Drugs Dermatol 2008;7:563-72","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.14.1735"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.02.007"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1159\/000182256"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-007-0010-y"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07562.x"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.09.017"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1159\/000121333"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1159\/000233234"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03389.x"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1159\/000017946"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2010.0815"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80313-2"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.018085"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2005.01.011"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06893.x"},{"key":"e_1_3_2_76_1","first-page":"1447","article-title":"Biologic therapies for psoriasis. A systematic review","volume":"33","author":"Boehncke WH","year":"2006","unstructured":"Boehncke WH, Prinz J, Gottlieb AB. Biologic therapies for psoriasis. A systematic review. J Rheumatol 2006;33:1447-51","journal-title":"J Rheumatol"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsymp.5650010"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01527.x"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1586\/17469872.2.3.335"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.2147\/btt.s2763"},{"key":"e_1_3_2_81_1","first-page":"546","article-title":"Anti-TNF agents for the treatment of psoriasis","volume":"8","author":"Kircik LH","year":"2009","unstructured":"Kircik LH, Del Rosso JQ. Anti-TNF agents for the treatment of psoriasis. J Drugs Dermatol 2009;8:546-59","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1159\/000232307"},{"key":"e_1_3_2_83_1","first-page":"334","article-title":"A range of targeted treatments using monoclonal antibodies in dermatology. Current and future practice","volume":"64","author":"Pierard-Franchimont C","year":"2009","unstructured":"Pierard-Franchimont C, Quatresooz P, Paquet P, A range of targeted treatments using monoclonal antibodies in dermatology. Current and future practice. Rev Med Liege 2009;64:334-8","journal-title":"Rev Med Liege"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2009.10.200"},{"key":"e_1_3_2_85_1","first-page":"147","article-title":"Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents","volume":"8","author":"Sobell JM","year":"2009","unstructured":"Sobell JM, Kalb RE, Weinberg JM. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents. J Drugs Dermatol 2009;8:147-54","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810652"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.4.2721"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:EJEP.0000020447.59150.f9"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh464"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.10.052"},{"key":"e_1_3_2_91_1","first-page":"1422","article-title":"Therapies for peripheral joint disease in psoriatic arthritis. A systematic review","volume":"33","author":"Soriano ER","year":"2006","unstructured":"Soriano ER, McHugh NJ. Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol 2006;33:1422-30","journal-title":"J Rheumatol"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22530"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.062323"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07562.x"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2008.02.006"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.2147\/btt.s12160335"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.01217.x"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03474.x"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.12.1654"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1159\/000162180"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1159\/000113945"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2008.07095"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20954"},{"key":"e_1_3_2_104_1","first-page":"25","article-title":"Psoriatic arthritis update","volume":"64","author":"Mease PJ","year":"2006","unstructured":"Mease PJ. Psoriatic arthritis update. Bull NYU Hosp Jt Dis 2006;64:25-31","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22800"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1159\/000260371"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.2147\/btt.s12160335"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328331b654"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2008.02.006"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02429.x"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.072256"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel322"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.10.1403"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2007.04.014"},{"key":"e_1_3_2_115_1","first-page":"563","article-title":"Psoriasis and the metabolic syndrome","volume":"7","author":"Gottlieb AB","year":"2008","unstructured":"Gottlieb AB, Dann F, Menter A. Psoriasis and the metabolic syndrome. J Drugs Dermatol 2008;7:563-72","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.04.031"},{"key":"e_1_3_2_117_1","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson LT","year":"2005","unstructured":"Jacobsson LT, Turesson C, Gulfe A, Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005;32:1213-8","journal-title":"J Rheumatol"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20407"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000077913.60364.D2"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2009.10.003"},{"key":"e_1_3_2_121_1","first-page":"438","article-title":"Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?","volume":"34","author":"Richette P","year":"2007","unstructured":"Richette P, Viguier M, Bachelez H, Psoriasis induced by anti-tumor necrosis factor therapy: a class effect? J Rheumatol 2007;34:438-9","journal-title":"J Rheumatol"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23864.x"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050500"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629010-00004"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02315.x"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23835"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02429.x"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.10.1403"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2009.01259.x"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630802441234"},{"key":"e_1_3_2_131_1","first-page":"339","article-title":"Cutaneous adverse reactions to monoclonal antibody treatments","volume":"64","author":"Pierard-Franchimont C","year":"2009","unstructured":"Pierard-Franchimont C, Pierard GE. Cutaneous adverse reactions to monoclonal antibody treatments. Rev Med Liege 2009;64:339-46","journal-title":"Rev Med Liege"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1586\/eci.09.18"},{"key":"e_1_3_2_133_1","first-page":"247","article-title":"Tumor necrosis factor-alpha inhibition and palmoplantar pustulosis: Janus-faced therapy?","volume":"34","author":"Dutz JP","year":"2007","unstructured":"Dutz JP. Tumor necrosis factor-alpha inhibition and palmoplantar pustulosis: Janus-faced therapy? J Rheumatol 2007;34:247-9","journal-title":"J Rheumatol"},{"key":"e_1_3_2_134_1","first-page":"380","article-title":"Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series","volume":"34","author":"Cohen JD","year":"2007","unstructured":"Cohen JD, Bournerias I, Buffard V, Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. J Rheumatol 2007;34:380-5","journal-title":"J Rheumatol"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.2.223"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27203"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2008.00915.x"},{"key":"e_1_3_2_138_1","first-page":"1411","article-title":"Anti-tumor necrosis factor-alpha-induced psoriasis","volume":"33","author":"Sari I","year":"2006","unstructured":"Sari I, Akar S, Birlik M, Anti-tumor necrosis factor-alpha-induced psoriasis. J Rheumatol 2006;33:1411-4","journal-title":"J Rheumatol"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2007.06.011"},{"key":"e_1_3_2_140_1","doi-asserted-by":"crossref","unstructured":"Saint Marcoux B De Bandt M. Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 2006:73:710-713","DOI":"10.1016\/j.jbspin.2006.02.010"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2005.04.004"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181441a68"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-008-0072-z"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.11.003"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.075663"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.2.198"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071094"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630701646172"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08606.x"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.03161.x"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.2147\/btt.s3251"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta13suppl2-07"},{"key":"e_1_3_2_153_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03389.x"},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.027"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.09.010"},{"key":"e_1_3_2_156_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08315.x"},{"key":"e_1_3_2_157_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21306"},{"key":"e_1_3_2_158_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666110-00008"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.057901"},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092767"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1159\/000260371"},{"key":"e_1_3_2_162_1","first-page":"887","article-title":"Adalimumab treatment of a patient with psoriasis suppurativa hallopeau associated osteoarthropathy","volume":"27","author":"Mueller RB","year":"2009","unstructured":"Mueller RB, Ogilvie A, Schwarz S, Adalimumab treatment of a patient with psoriasis suppurativa hallopeau associated osteoarthropathy. Clin Exp Rheum 2009;27:887","journal-title":"Clin Exp Rheum"},{"key":"e_1_3_2_163_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.111856"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1027411"},{"key":"e_1_3_2_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.020"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.06.008"},{"key":"e_1_3_2_167_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.087288"},{"key":"e_1_3_2_168_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100334"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.2010.500283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T01:13:22Z","timestamp":1770945202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.2010.500283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,13]]},"references-count":166,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1517\/14712598.2010.500283"],"URL":"https:\/\/doi.org\/10.1517\/14712598.2010.500283","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,13]]}}}